New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export ISRG’s income statement to Excel — free account
Intuitive Surgical, Inc.
ISRGHealthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −23.6%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
399.33
7.91
−1.94%
After hours trading: 400.00, up 0.17%, last trade 4:23pm Eastern.
Follow ISRG
Alert me
Revenue to profit Twelve months to Sep 30, 2026
Of every $100 of revenue, $25.68 was left as profit. Gross margin has risen three quarters running, from 66.0% to 67.2%. What is an income statement?
| Revenue | 11.6 | 100.0% |
|---|---|---|
| Cost of revenue | −3.8 | −32.8% |
| Gross profit | 7.8 | 67.2% |
| Research & development | −1.5 | −12.9% |
| Selling, general & admin | −2.6 | −22.0% |
| Other operating costs | −0.5 | −3.9% |
| Operating income | 3.3 | 28.4% |
| Other income, net | +0.3 | 2.9% |
| Income tax | −0.6 | −5.6% |
| Net income | 3.0 | 25.7% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $10.1B | $10.6B | $11.0B | $11.6B |
| Operating income | $2.9B | $3.2B | $3.5B | $3.3B |
| Net income | $2.9B | $3.0B | $3.2B | $3.0B |
| Net margin (right axis) | 28.6% | 28.3% | 28.6% | 25.7% |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Revenue |
+8 more TTM periods Free account |
10,064.70 | 10,582.10 | 11,034.40 | 11,578.00 |
Cost of Revenue |
3,422.40 | 3,567.00 | 3,676.80 | 3,798.50 | |
Gross Profit |
6,642.30 | 7,015.10 | 7,357.60 | 7,779.50 | |
R&D Expenses |
1,311.80 | 1,357.50 | 1,414.80 | 1,493.70 | |
SG&A Expenses |
2,385.00 | 2,434.90 | 2,491.60 | 2,551.70 | |
Operating Income |
2,945.50 | 3,222.70 | 3,451.20 | 3,284.10 | |
Non-operating Income/Expense |
365.90 | 360.60 | 354.60 | 334.90 | |
| 3,311.40 | 3,583.30 | 3,805.80 | 3,619.00 | ||
Income Tax Provision |
434.80 | 584.40 | 647.90 | 645.90 | |
Income after Tax |
2,876.60 | 2,998.90 | 3,157.90 | 2,973.10 | |
Dividends (Preferred) |
— | — | 0.00 | 0.00 | |
Non-Controlling Interest |
20.60 | 19.80 | 19.10 | 15.90 | |
Net Income Common |
2,856.00 | 2,979.10 | 3,138.80 | 2,957.20 | |
EPS (Basic) |
8.01 | 8.37 | 8.84 | 8.36 | |
EPS (Diluted) |
7.89 | 8.25 | 8.73 | 8.27 | |
Shares (Basic, Weighted) |
357.38 | 356.73 | 355.63 | 353.73 | |
Shares (Diluted, Weighted) |
363.30 | 362.10 | 360.40 | 357.85 | |
Gross Margin |
66.00% | 66.29% | 66.68% | 67.19% | |
EBIT Margin |
29.27% | 30.45% | 31.28% | 28.37% | |
EBT margin |
32.90% | 33.86% | 34.49% | 31.26% | |
Net Profit Margin |
28.38% | 28.15% | 28.45% | 25.54% | |
Free Cash Flow Margin |
24.75% | 27.22% | 29.62% | 31.47% | |
EBITDA |
3,622.60 | 3,957.70 | 4,253.80 | 4,135.80 | |
EBIT |
2,945.50 | 3,222.70 | 3,451.20 | 3,284.10 | |
EPS (Diluted, from Cont. Ops) |
7.93 | 8.30 | 8.78 | 8.31 | |
EPS (Diluted, Consolidated) |
7.93 | 8.30 | 8.78 | 8.31 | |
EPS (Basic, Consolidated) |
8.06 | 8.42 | 8.89 | 8.40 | |
Shares (Diluted, Average) |
362.73 | 361.53 | 359.83 | 357.28 | |
EPS (Basic, from Continuous Ops) |
8.06 | 8.42 | 8.89 | 8.40 | |
Income from Continuous Operations |
2,876.60 | 2,998.90 | 3,157.90 | 2,973.10 | |
Consolidated Net Income/Loss |
2,876.60 | 2,998.90 | 3,157.90 | 2,973.10 | |
EBITDA Margin |
35.99% | 37.40% | 38.55% | 35.72% | |
Operating Cash Flow Margin |
30.11% | 31.76% | 33.59% | 35.32% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 2, 2026